Weissert, R. and Jendroska, K. and Wagner, T. (2015) RETURN II: Investigation of clinical disease and safety outcomes in RMS-patients receiving subcutaneous (sc) interferon (IFN) beta-1a following discontinuation of natalizumab. EUROPEAN JOURNAL OF NEUROLOGY, 22 (Suppl1). p. 353. ISSN 1351-5101, 1468-1331
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Neurologie |
| Depositing User: | Petra Gürster |
| Date Deposited: | 21 Aug 2020 11:31 |
| Last Modified: | 21 Aug 2020 11:31 |
| URI: | https://pred.uni-regensburg.de/id/eprint/5339 |
Actions (login required)
 |
View Item |
